| Data |
Ora |
Fonte |
Titolo |
|---|
| 19/12/2024 | 12:38 | GLOBE | Data and Safety Monitoring Board Reviews Interim Safety Data.. |
| 11/12/2024 | 13:02 | GLOBE | Ocugen CEO to Present at Oppenheimer Movers in Rare Disease.. |
| 03/12/2024 | 15:50 | EDGAR2 | Form 8-K - Current report |
| 02/12/2024 | 22:15 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 27/11/2024 | 13:09 | GLOBE | Ocugen CEO to Present at NobleCon20 – Noble Capital Markets’.. |
| 26/11/2024 | 22:50 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 20/11/2024 | 13:30 | GLOBE | Ocugen Announces European Medicines Agency Grants Orphan.. |
| 19/11/2024 | 13:02 | GLOBE | Ocugen Announces Compelling Preliminary Data for OCU410—a.. |
| 15/11/2024 | 22:17 | EDGAR2 | Form 3 - Initial statement of beneficial ownership of.. |
| 15/11/2024 | 22:05 | EDGAR2 | Form 8-K - Current report |
| 14/11/2024 | 21:25 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 12/11/2024 | 15:55 | EDGAR2 | Form 8-K - Current report |
| 08/11/2024 | 22:30 | EDGAR2 | Form 8-K - Current report |
| 08/11/2024 | 19:43 | EDGAR2 | Form 8-K - Current report |
| 08/11/2024 | 12:45 | GLOBE | Ocugen Provides Business Update with Third Quarter 2024.. |
| 07/11/2024 | 12:30 | GLOBE | Ocugen Secures $30 Million in Debt Funding |
| 28/10/2024 | 11:30 | GLOBE | Ocugen Clinical Showcase Highlighting Progress in Retinal.. |
| 22/10/2024 | 13:02 | GLOBE | Data and Safety Monitoring Board Approves Initiation of.. |
| 17/10/2024 | 13:30 | GLOBE | Ocugen to Host Conference Call on Friday, November 8 at 8:30.. |
| 10/10/2024 | 13:00 | GLOBE | Ocugen to Participate in 2024 Maxim Healthcare Virtual.. |
| 09/10/2024 | 12:30 | GLOBE | Ocugen, Inc. Announces Removal of Clinical Hold on.. |
| 02/10/2024 | 12:30 | GLOBE | Ocugen to Present at the 2024 Cell & Gene Meeting on the.. |
| 26/9/2024 | 22:27 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 24/9/2024 | 13:30 | GLOBE | Ocugen to Participate in a Fireside Chat at Chardan’s 8th.. |
| 09/9/2024 | 12:30 | GLOBE | Ocugen Chairman, CEO & Co-founder, Dr. Shankar Musunuri, to.. |
| 05/9/2024 | 13:00 | GLOBE | Ocugen CSO to Participate in 5th Annual Gene Therapy for.. |
| 03/9/2024 | 13:30 | GLOBE | Ocugen to Participate in a Fireside Chat at the H.C... |
| 28/8/2024 | 12:30 | GLOBE | Ocugen Announces Completion of Dosing in Subjects with.. |
| 26/8/2024 | 13:02 | GLOBE | Ocugen, Inc. Announces Health Canada Approval to Initiate.. |
| 20/8/2024 | 15:00 | PRNUS | Ocugen, Inc. Investor Alert (NASDAQ: OCGN): Schubert.. |
| 16/8/2024 | 22:16 | EDGAR2 | Form 144 - Report of proposed sale of securities |
| 13/8/2024 | 14:00 | EDGAR2 | Form 8-K - Current report |
| 08/8/2024 | 19:03 | EDGAR2 | Form 8-K - Current report |
| 08/8/2024 | 12:45 | GLOBE | Ocugen Provides Business Update with Second Quarter 2024.. |
| 08/8/2024 | 12:06 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 05/8/2024 | 13:18 | EDGAR2 | Form 8-K - Current report |
| 05/8/2024 | 12:30 | GLOBE | Ocugen, Inc. Announces FDA Approval of Expanded Access.. |
| 02/8/2024 | 21:22 | GLOBE | Ocugen, Inc. Announces Closing of $35 Million Public.. |
| 01/8/2024 | 15:18 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 01/8/2024 | 15:16 | EDGAR2 | Form 8-K - Current report |
| 01/8/2024 | 03:15 | GLOBE | Ocugen, Inc. Announces Pricing of $35 Million Public.. |
| 31/7/2024 | 22:16 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 31/7/2024 | 22:15 | GLOBE | Ocugen, Inc. Announces Proposed Public Offering of Common.. |
| 29/7/2024 | 13:02 | GLOBE | Ocugen to Host Conference Call on Thursday, August 8 at 8:30.. |
| 25/7/2024 | 12:30 | GLOBE | Ocugen, Inc. Announces Completion of Dosing in Subjects with.. |
| 08/7/2024 | 22:31 | EDGAR2 | Form 8-K - Current report |
| 21/6/2024 | 13:00 | GLOBE | Ocugen Announces Data and Safety Monitoring Board Approves.. |
| 20/6/2024 | 12:30 | GLOBE | Ocugen, Inc. Announces First Patient Dosed in Phase 3.. |
| 18/6/2024 | 22:29 | EDGAR2 | Form DEFA14A - Additional definitive proxy soliciting.. |
| 06/6/2024 | 22:31 | EDGAR2 | Form 8-K - Current report |
Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
